Pamine Side Effects

Generic name: methscopolamine

Medically reviewed by Drugs.com. Last updated on Oct 25, 2024.

Note: This document provides detailed information about Pamine.

Applies to methscopolamine: oral tablets Side Effects associated with methscopolamine. Some dosage forms listed on this page may not apply specifically to the brand name Pamine.

Applies to methscopolamine: oral tablets.

Side effects include:

Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).

For healthcare professionals

Applies to methscopolamine: oral tablet.

Cardiovascular adverse events

• Frequency not reported: Tachycardia, palpitation^[Ref]

Hypersensitivity

• Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis^[Ref]

Nervous system

• Frequency not reported: Headaches, drowsiness, dizziness, loss of taste^[Ref]

Ocular

• Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension^[Ref]

Gastrointestinal

• Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia^[Ref]

Dermatologic

• Frequency not reported: Decreased sweating, urticaria and other dermal manifestations^[Ref]

Genitourinary

• Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation^[Ref]

Other

• Frequency not reported: Weakness^[Ref]

Psychiatric

• Frequency not reported: Nervousness, mental confusion, insomnia^[Ref]

Further information

Pamine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer